Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 3.79 EUR -4.1% Market Closed
Market Cap: 178.6m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Wall Street
Price Targets

NANO Price Targets Summary
Nanobiotix SA

Wall Street analysts forecast NANO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NANO is 12.53 EUR with a low forecast of 9.6 EUR and a high forecast of 16.8 EUR.

Lowest
Price Target
9.6 EUR
153% Upside
Average
Price Target
12.53 EUR
230% Upside
Highest
Price Target
16.8 EUR
343% Upside
Nanobiotix SA Competitors:
Price Targets
RARE
Ultragenyx Pharmaceutical Inc
95% Upside
688520
Sinocelltech Group Ltd
53% Upside
206650
EuBiologics Co Ltd
9% Downside
ACLX
Arcellx Inc
7% Downside
ANIK
Anika Therapeutics Inc
108% Upside
TSVT
2Seventy Bio Inc
97% Upside
ALERS
Eurobio Scientific SA
19% Upside
MRUS
Merus NV
76% Upside

Revenue
Forecast

Revenue Estimate
Nanobiotix SA

For the last 8 years the compound annual growth rate for Nanobiotix SA's revenue is 81%. The projected CAGR for the next 3 years is 17%.

81%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nanobiotix SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nanobiotix SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NANO's stock price target?
Price Target
12.53 EUR

According to Wall Street analysts, the average 1-year price target for NANO is 12.53 EUR with a low forecast of 9.6 EUR and a high forecast of 16.8 EUR.

What is Nanobiotix SA's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Nanobiotix SA's revenue is 81%. The projected CAGR for the next 3 years is 17%.

Back to Top